1 |
K M. Chitty et al. (2016). Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study. Aust NZJ Psychiatry, 50(4), 352-362.
DOI
|
2 |
S. L. Einfeld et al. (2011). Comorbidity of intellectual disability and mental disorder in children and adolescents: a systematic review. J Intellect Dev Disabil., 36(2), 137-143.
DOI
|
3 |
Y. H. Kang. (2008). Encyclopedia of Life Science. Academy Books.
|
4 |
M. A Song & H. J. Hong. (2013). Use of Antipsychotics in Attention-Deficit Hyperactivity Disorder. Korean College of Neuropsychopharmcology, establishment 11-17.
|
5 |
E. Y. Oh, et al. (2000). Comparison of Therapeutic Efficacy between Haloperidol and Risperdone in Tic Disirders. Korean College of Neuropsychopharmcology, 11(3), 270-277.
|
6 |
N. Ji & R. L. Findling. (2015). Anupdate on pharmacotherapy for autism Spectrum Disorder in Children and Adolescents. Curr Opin Psychiatry, 28(2), 91-101.
DOI
|
7 |
J. S. Choi. (1993). Pharmacological Treatment in pervasive developmental disorders. J. the Korean Academy of Child and Adolescent Psychiatry. 4(1), 27-38.
|
8 |
T. Hayashi et al. (2004). Actual Conditions of Use of Anti-Psychotic Drugs in Institute for People with Intellectual Disabilities. Bulletin of the School of Nursing, Yamaguchi Prefectural University, 8, 1-4.
|
9 |
Y. Ono. (2000). Usage status of psychotropic medication in Mental retardation. Clinical psychiatry, 47(7), 697-703.
|
10 |
N. D. Goli et al. (2016). Intellectual Disability in Children; a Systematic Review. Quarterly of International Archives of Health Sciences. 3(2), 27-36.
DOI
|
11 |
H. Nakayama. (2001). A Questionnaire survey on the psychiatric conditions of patients in residential facilities for mentally handicapped children. Japanese Journal of Child and Adolescent Psychiatry. 42(1), 57-65.
|
12 |
K. Tanaka et al. (2006). Clinical Characteristics and Pharmacotherapy of Extremely Disruptive Behavior Disorders in People with Mental Retardation. No To Hattatsu, 38, 19-24.
|
13 |
M, Weiss et. al. (2009). A naturalistic study of predictors and risks of atypical antipsychotic use in an attention-deficit/hyperactivity disorder clinic. J Child Adolesc Psychopharmacol, 19, 575-582.
DOI
|
14 |
H. J. Yu. (2018). The clinical approach of mental health to the socially underprivileged such as developmnetal disability etc. Classroon of a psychiatrist in Seoul National University, SHUBH, The psychiatry department, presentation material.
|
15 |
M. S. Kim & H. J., Kim. (2011). Understand and Education of Special Children for Special Education Teacher. Changjisa. 140-146.
|
16 |
D. L. Bowring et al. (2017). Challenging behaviors in adults with intellectual disability: A total poupulation study and exploration of risk indices. Br J Clin Psychol. 56(1). 16-32
DOI
|
17 |
J. Y. Kwon. (2009). Diagnostic Evaluation and Rehabilitation in Children with Intellectual Disabilities. Korean Med Assoc. 52(6), 601-610.
DOI
|
18 |
M. Y. Choi. (2009). Health and Medical Care for People With Disability. Health And welfare Forum, 46-63.
|
19 |
S. B. Lee et. al. (2016). Differences of obstetric complications and clinical characteristics between autism spectrum disorder and Intellectual Disability. Psychosmatic, 24(2), 165-173.
|
20 |
E. Y. Oh et. al. (2013). Comparison of Therapeutic Efficacy between Haloperidol and Risperidone in Tic Disorders. The Korean Journal of Psychopharmacology, 11(3), 270-277
|
21 |
H. W. Sin. (2011). Recognition of the importance and practice of the assessment of rehabilitation services and therapeutic facilities for disables person. Unpublished master's dissertation, Kwangwoon University.
|
22 |
H. K. Lim(2014). Social Worker's perception of minimum service standards of residental care facilities for the disabled. Unpublished master's dissertation, Ulsan University.
|
23 |
Y. I. Chung & S. H. Park. (2006). Development History of Antipsychotic Drugs. The Korean Journal of Psychopharmacology, 17(3), 283-290.
|
24 |
S. K. Park.(2016). The present condition and tasks of deinstitutionalization of the people with disabilities in Korea. Journal of Intellectual Disabilities, 18(1), 205-234.
|
25 |
Y. Inoue et al. (2016). Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities : A cohort Study Using a Large-Scale Health Insurance Database. Psychiat. neurol. Jap, 118(11), 823-833.
|
26 |
Japanese Association on intellectual & Welfare Disabilities. (2016). National Intellectual Disabilities Report on actual condition of entrance facility. 235-295.
|
27 |
T. Doan et. al. (2014). Psychotropic medication use in adolescents with intellectual disability living in the community. Pharmacoepidemiol Drug Saf, 23(1), 69-76.
DOI
|
28 |
I. Kimura et. al.(2016). Treatment for self-injurious in mentally hadicapped populatons -a report from our practice. Hattatsu, 48, 117-121.
|
29 |
S. W, Hsu er. al. (2014). Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007. Res Dev Disabil., 35(2), 364-372.
DOI
|
30 |
J. S. Kwon & K. J. Lee. (2004). Atypical Antipsychotics : The Benefit and Disadvantage. Korean J Psychopharmacol, 15(2), 125-134.
|
31 |
J. W. Park & H. Y. Im.(1993). The Experiences of Antipsychotic Agents in Mentally Disabled. Korean J Str Res, 20, 21-30.
|